收藏切换
Post-marketing surveillance analysis of human papillomavirus vaccine safety in Hebei province from 2018 to 2022
收藏切换
Shifan WANG1, Li SUN2, Yafei WANG2, Jinghui WANG2, Jing LI2, Yihan WANG2, Qi LI2
Chinese Journal of Public Health | 2025, 41(4) : 464 - 467
Less
收藏切换
Chinese Journal of Public Health | 2025, 41(4): 464-467
• Survey and Report •
Post-marketing surveillance analysis of human papillomavirus vaccine safety in Hebei province from 2018 to 2022
Full
Shifan WANG1, Li SUN2, Yafei WANG2, Jinghui WANG2, Jing LI2, Yihan WANG2, Qi LI2
Affiliations
  • 1School of Public Health, North China University of Science and Technology, Tangshan 063210, China
  • 2Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China
Published: 2025-04-10 doi: 10.11847/zgggws1144008
Outline
收藏切换
Objective

To analyze the characteristics of adverse events following immunization (AEFI) with human papillomavirus (HPV) vaccines in Hebei province from 2018 to 2022 and to evaluate the safety of these vaccines.

Methods

AEFI cases following HPV vaccination in Hebei province from January 1, 2018, to December 31, 2022, were collected through the AEFI surveillance module of the Chinese Center for Disease Control and Prevention Information System. Descriptive analysis was conducted on the characteristics and reported incidence of AEFI.

Results

A total of 128 HPV vaccine AEFI cases were reported in Hebei province from 2018 to 2022, with an average annual reported incidence of 3.03/100 000 doses. The reported incidences of AEFI for the bivalent, quadrivalent, and 9-valent HPV vaccines (HPV2, HPV4, and HPV9, respectively) were 2.39/100 000 doses, 3.61/100 000 doses, and 3.38/100 000 doses, respectively. The AEFI reporting rate for HPV2 was lower than that for HPV4 (χ2=3.931, P<0.05). The reported incidences of general vaccine reactions for HPV2, HPV4, and HPV9 were 2.22/100 000 doses, 2.63/100 000 doses, and 2.74/100 000 doses, respectively. The reported incidences of local redness and swelling and fever were both higher than that of local induration (χ2=12.500, 5.918, both P<0.05). The reported incidences of rare reactions were 0.11/100 000 doses, 0.60/100 000 doses, and 0.55/100 000 doses for HPV2, HPV4, and HPV9, respectively. The incidence of vaccine reactions for both HPV4 and HPV9 were higher than that for HPV2 (χ2=5.763, 4.705, both P<0.05). All AEFI cases related to HPV vaccines recovered or improved, with a good overall outcome.

Conclusions

The reported incidences of AEFI for HPV vaccines in Hebei province were within acceptable limits, indicating good overall safety.

bivalent human papillomavirus vaccine  /  quadrivalent human papillomavirus vaccine  /  9-valent human papillomavirus vaccine  /  suspected adverse events following immunization  /  Hebei province
王诗璠, 孙丽, 王亚菲, 王晶辉, 李静, 王易寒, 李琦. 2018—2022年河北省人乳头瘤病毒疫苗上市后安全性监测分析. 中国公共卫生, 2025 , 41 (4) : 464 -467 . DOI: 10.11847/zgggws1144008
Shifan WANG, Li SUN, Yafei WANG, Jinghui WANG, Jing LI, Yihan WANG, Qi LI. Post-marketing surveillance analysis of human papillomavirus vaccine safety in Hebei province from 2018 to 2022[J]. Chinese Journal of Public Health, 2025 , 41 (4) : 464 -467 . DOI: 10.11847/zgggws1144008
Year 2025 volume 41 Issue 4
95
39
Cite this Article
BibTeX
Article Info
doi: 10.11847/zgggws1144008
  • Receive Date:2024-01-11
  • Online Date:2026-10-25
  • Published:2025-04-10
Article Data
Affiliations
History
  • Received:2024-01-11
  • Revised:2024-11-20
  • Accepted:2025-03-12
Affiliations
    1School of Public Health, North China University of Science and Technology, Tangshan 063210, China
    2Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China

Corresponding:

LI Qi, E-mail:
References
Share
https://castjournals.cast.org.cn/joweb/zgggws/EN/10.11847/zgggws1144008
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT